Basic/Clinical Science Session
Unraveling C3 Glomerulopathy: Insights into Diagnosis, Management, and Therapeutic Strategies
October 27, 2024 | 09:30 AM - 11:30 AM
Location: Room 6A, Convention Center
Session Description
This session unravels the intricacies of C3 glomerulopathy, providing comprehensive insights into its diagnosis, management, and emerging therapeutic strategies. Through a multidimensional approach, we delve into the latest advancements in diagnostics, effective management protocols, and the evolving landscape of therapeutic interventions.
ASN thanks the Kidney Health Initiative (KHI) for assistance with this session.
Support is provided by an educational grant from Travere Therapeutics, Inc.
Learning Objective(s)
- Summarize comprehensive management strategies encompassing pharmacological and nonpharmacological interventions for patients diagnosed with C3 glomerulopathy
- Describe recent and ongoing clinical trials, providing an overview of novel treatments and potential future directions in C3 glomerulopathy research
- Outline the latest advancements in therapeutic interventions, including immunomodulatory and targeted treatments, shaping the landscape of C3 glomerulopathy management
- Discuss the local and systemic drivers of complement dysregulation in C3 glomerulopathy
Learning Pathway(s)
- Glomerular Diseases
- Pediatric Nephrology
Moderators
Presentations
- Insights into the Diagnosis of C3 Glomerulopathy
09:30 AM - 10:00 AM
- Drivers of Disease in C3 Glomerulopathy
10:00 AM - 10:30 AM
- Strategic Approaches in the Management of C3 Glomerulopathy
10:30 AM - 11:00 AM
- Defining Effective End Points for C3 Glomerulopathy
11:00 AM - 11:30 AM